BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24523119)

  • 1. Systems biology approaches to enzyme kinetics: analyzing network models of drug metabolism.
    Finn NA; Kemp ML
    Methods Mol Biol; 2014; 1113():317-34. PubMed ID: 24523119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems Biology Approaches to Enzyme Kinetics.
    Finn NA; Raddatz AD; Kemp ML
    Methods Mol Biol; 2021; 2342():419-440. PubMed ID: 34272703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme kinetics in drug metabolism: fundamentals and applications.
    Nagar S; Argikar UA; Tweedie DJ
    Methods Mol Biol; 2014; 1113():1-6. PubMed ID: 24523105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymes or redox couples? The kinetics of thioredoxin and glutaredoxin reactions in a systems biology context.
    Pillay CS; Hofmeyr JH; Olivier BG; Snoep JL; Rohwer JM
    Biochem J; 2009 Jan; 417(1):269-75. PubMed ID: 18694397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of the unbound drug concentration in enzyme kinetics.
    Waters NJ; Obach RS; Di L
    Methods Mol Biol; 2014; 1113():119-45. PubMed ID: 24523111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery.
    Zhang R; Wong K
    Expert Opin Drug Discov; 2017 Jan; 12(1):17-37. PubMed ID: 27784173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameter identification of in vivo kinetic models: limitations and challenges.
    Heijnen JJ; Verheijen PJ
    Biotechnol J; 2013 Jul; 8(7):768-75. PubMed ID: 23813763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
    Schrattenholz A; Groebe K; Soskic V
    Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling.
    Galetin A
    Methods Mol Biol; 2014; 1113():255-88. PubMed ID: 24523117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of drugs: risk and drug design.
    Walsh JS; Miwa GT
    Annu Rev Pharmacol Toxicol; 2011; 51():145-67. PubMed ID: 21210745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of cellular processes: methods, data, and requirements.
    Millat T; Wolkenhauer O; Fischer RJ; Bahl H
    Methods Mol Biol; 2011; 696():429-47. PubMed ID: 21063964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.
    Yengi LG
    Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case study 3. Application of basic enzyme kinetics to metabolism studies: real-life examples.
    Li Y; McCabe M; Podila L; Tracy TS; Tweedie DJ
    Methods Mol Biol; 2014; 1113():441-60. PubMed ID: 24523124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology of cell behavior.
    Valeyev NV; Bates DG; Umezawa Y; Gizatullina AN; Kotov NV
    Methods Mol Biol; 2010; 662():79-95. PubMed ID: 20824467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal control of metabolic networks with saturable enzyme kinetics.
    Oyarzuun DA
    IET Syst Biol; 2011 Mar; 5(2):110-9. PubMed ID: 21405199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems biology approach to drug discovery.
    Zhu J; Zhang B; Schadt EE
    Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
    Zhang L; Zhang Y; Huang SM
    Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic activation of chemicals to toxic metabolites.
    Guengerich FP; Liebler DC
    Crit Rev Toxicol; 1985; 14(3):259-307. PubMed ID: 3926381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.
    Shou M
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):66-77. PubMed ID: 15679174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.